Search

A UT Southwestern Medical Center researcher and his colleagues developed a novel presurgical vaccine strategy that may prevent dangerous infections in patients receiving hip, knee, and other joint replacements.

Hispanic college students who encounter racial or ethnic discrimination on social media are more likely to turn to alcohol as a coping mechanism, according to a study led by a UT Southwestern Medical Center researcher.

Today the Dallas Mavericks and UT Southwestern Medical Center announced a multiyear expansion of their strategic partnership. UT Southwestern, the team’s Official Health Care Partner since 2019, will now also serve as the Official Team Doctors for the franchise. The UT Southwestern logo will appear

The Centers for Medicare & Medicaid Services (CMS) announced that the Southwestern Health Resources Accountable Care Network (SWHR) saved more than $52 million in 2019.

A team led by UT Southwestern Medical Center scientists has identified a specific stage of neurodevelopment when differentiating neural cells produce fewer ribosomes, which are responsible for making proteins.

Inactivating a gene in young songbirds that’s closely linked with autism spectrum disorder (ASD) prevents the birds from forming memories necessary to accurately reproduce their fathers’ songs, a new study led by UT Southwestern shows.

Kidney cancers that metastasize to the pancreas have a fundamentally different biology from those that metastasize elsewhere

The CLOCK gene, which serves as a master controller of circadian rhythms, may play a key role in the extraordinary cognitive abilities of humans as well as neuropsychiatric disorders that afflict them, UT Southwestern Medical Center researchers report.

By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately predict which patients with breast cancer will respond to immunotherapies.

Shutting down a gene called PRMT5 stopped metastatic estrogen receptor-positive (ER+) breast cancer cells from growing after they acquired resistance to a standard therapy known as CDK4/6 inhibitors, UT Southwestern Medical Center researchers showed in a new study.